{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+support&page=68", "query": { "intervention": "Standard support", "page": 68 }, "page_size": 10 }, "pagination": { "page": 68, "page_size": 10, "total_count": 2146, "total_pages": 215, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+support&page=69&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+support&page=67&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-04T10:36:05.810Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04743804", "title": "Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Thrombotic Microangiopathy" ], "interventions": [ { "name": "Ravulizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Best Supportive Care", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2021-06-29", "completion_date": "2022-12-22", "has_results": true, "last_update_posted_date": "2024-10-01", "last_synced_at": "2026-11-04T10:36:05.810Z", "location_count": 20, "location_summary": "Tucson, Arizona • Orange, California • Washington D.C., District of Columbia + 14 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT04743804" }, { "nct_id": "NCT07176000", "title": "Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Carcinoma" ], "interventions": [ { "name": "Patient Navigation", "type": "BEHAVIORAL" }, { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Best Practice", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" }, { "name": "Electronic Health Record Review", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 237, "start_date": "2026-10-01", "completion_date": "2029-04-30", "has_results": false, "last_update_posted_date": "2026-10-27", "last_synced_at": "2026-11-04T10:36:05.810Z", "location_count": 2, "location_summary": "Auburn, Washington • Shelton, Washington", "locations": [ { "city": "Auburn", "state": "Washington" }, { "city": "Shelton", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT07176000" }, { "nct_id": "NCT06512194", "title": "Investigation to Understand and Optimize Psilocybin", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Depression" ], "interventions": [ { "name": "Psilocybin", "type": "DRUG" }, { "name": "Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)", "type": "DEVICE" }, { "name": "Sham taVNS", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Charles Raison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 141, "start_date": "2025-05-13", "completion_date": "2029-05", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-11-04T10:36:05.810Z", "location_count": 1, "location_summary": "Edwards, Colorado", "locations": [ { "city": "Edwards", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06512194" }, { "nct_id": "NCT02949362", "title": "Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Short Bowel Syndrome" ], "interventions": [ { "name": "Teduglutide", "type": "DRUG" }, { "name": "SOC", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 29, "start_date": "2016-12-09", "completion_date": "2020-07-14", "has_results": true, "last_update_posted_date": "2025-03-19", "last_synced_at": "2026-11-04T10:36:05.810Z", "location_count": 10, "location_summary": "Los Angeles, California • Indianapolis, Indiana • Boston, Massachusetts + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02949362" }, { "nct_id": "NCT04830969", "title": "Impact of Periodontal Therapy on Patients With Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type II", "Periodontitis" ], "interventions": [ { "name": "Chlorhexidine gluconate oral rinse", "type": "DRUG" }, { "name": "Scaling & Root Planing", "type": "PROCEDURE" }, { "name": "Soft Picks", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "PROCEDURE", "DEVICE" ], "sponsor": "State University of New York at Buffalo", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "ALL", "summary": "25 Years and older" }, "enrollment_count": 116, "start_date": "2016-11-08", "completion_date": "2021-01-28", "has_results": true, "last_update_posted_date": "2023-03-01", "last_synced_at": "2026-11-04T10:36:05.810Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04830969" }, { "nct_id": "NCT02655354", "title": "A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Posttraumatic Stress Disorder", "Depression", "Alcohol-Related Disorders", "Suicidal Ideation", "Substance-Related Disorders", "Mild Cognitive Impairment", "Quality of Life", "Pain", "Wounds and Injury", "Brain Injuries", "Chronic Disease" ], "interventions": [ { "name": "Motivational Interviewing", "type": "BEHAVIORAL" }, { "name": "Cognitive Behavioral Therapy Elements", "type": "BEHAVIORAL" }, { "name": "Care Management", "type": "BEHAVIORAL" }, { "name": "Fluoxetine", "type": "DRUG" }, { "name": "Fluvoxamine", "type": "DRUG" }, { "name": "Paroxetine", "type": "DRUG" }, { "name": "Sertraline", "type": "DRUG" }, { "name": "Citalopram", "type": "DRUG" }, { "name": "Venlafaxine", "type": "DRUG" }, { "name": "Duloxetine", "type": "DRUG" }, { "name": "Mirtazapine", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Trazodone", "type": "DRUG" }, { "name": "Prazosin", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 635, "start_date": "2015-10", "completion_date": "2019-11", "has_results": true, "last_update_posted_date": "2021-07-02", "last_synced_at": "2026-11-04T10:36:05.810Z", "location_count": 24, "location_summary": "Scottsdale, Arizona • Beverly Hills, California • Sacramento, California + 20 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02655354" }, { "nct_id": "NCT01875354", "title": "A Prospective Study Investigating the Effects of a Novel Weight Management Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Overweight" ], "interventions": [ { "name": "Dietary Supplements and TR90 Eating Plan", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo and Low Fat Eating Plan", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Pharmanex", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 141, "start_date": "2013-05", "completion_date": "2014-11", "has_results": false, "last_update_posted_date": "2017-04-05", "last_synced_at": "2026-11-04T10:36:05.810Z", "location_count": 1, "location_summary": "Logan, Utah", "locations": [ { "city": "Logan", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01875354" }, { "nct_id": "NCT02355080", "title": "A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Substance-related Disorders" ], "interventions": [ { "name": "On-site bundled rapid HIV/HCV testing", "type": "BEHAVIORAL" }, { "name": "Standard of care (SOC)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 134, "start_date": "2016-04", "completion_date": "2017-07", "has_results": false, "last_update_posted_date": "2018-02-23", "last_synced_at": "2026-11-04T10:36:05.810Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02355080" }, { "nct_id": "NCT07456566", "title": "Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Inflammatory Bowel Diseases", "Ulcerative Colitis", "Crohn Disease" ], "interventions": [ { "name": "Digital self-management program", "type": "BEHAVIORAL" }, { "name": "Standard Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2026-07-20", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-11-04T10:36:05.810Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07456566" }, { "nct_id": "NCT05302583", "title": "Aromatherapy Inhaler Use for HSCT Distress", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer Distress", "Cancer Coping", "Hematopoetic Stem Cell Transplant", "Aromatherapy" ], "interventions": [ { "name": "Aromatherapy Stick", "type": "OTHER" }, { "name": "Standard of Care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2025-06-16", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-11-04T10:36:05.810Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05302583" } ] }